US 11773076
Crystalline forms of a somatostatin modulator
granted A61PA61P3/00
Quick answer
US patent 11773076 (Crystalline forms of a somatostatin modulator) held by CRINETICS PHARMACEUTICALS, INC. expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRINETICS PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61P, A61P3/00